You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 142 No. 9, September 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Review Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Evidence-Based Medicine
 •Surgical Oncology
 •Review
 •Randomized Controlled Trial
 •Skin Cancer
 •Dermatology
 •Melanoma
 •Alert me on articles by topic

Excision Margins for Primary Cutaneous Melanoma

Updated Pooled Analysis of Randomized Controlled Trials

Marko B. Lens, MD, PhD; Paul Nathan, MD; Veronique Bataille, MD, PhD

Arch Surg. 2007;142(9):885-891.

Objective  To determine the effectiveness of wide vs narrow excision margins in the treatment of primary cutaneous melanoma.

Data Sources  We conducted a search of MEDLINE and the Cochrane Controlled Trials Register as well as a manual search of the reference lists of all relevant papers. No language or date restrictions were applied.

Study Selection  Only prospective randomized trials were included.

Data Extraction  Two reviewers independently extracted the data from each study. Outcomes evaluated were local and locoregional recurrences and overall mortality. Data were analyzed using Cochrane Collaboration Review Manager software.

Data Synthesis  Five randomized trials comprising 3313 participants were retrieved and analyzed. Pooled data showed no statistically significant difference in overall mortality when comparing wide vs narrow excision margins (odds ratio, 0.98; 95% confidence interval, 0.72-1.22; and test for overall effect of P = .88). There was no statistically significant difference in the occurrence of locoregional recurrence between 2 groups of patients (odds ratio, 1.18; 95% confidence interval, 0.98-1.41; and test for overall effect not significant at P = .08). Although statistically significant heterogeneity was not detected among included trials, there was considerable clinical heterogeneity.

Conclusions  Although this meta-analysis did not show any statistically significant difference between patients treated with wide or narrow excision margins insofar as overall mortality and locoregional and local recurrences, current evidence is insufficient to address the optimal excision margins for all types of melanomas. Further research is required to establish the appropriate local treatment for different types of primary melanoma and subgroups of patients.


Author Affiliations: Genetic Epidemiology Unit, St Thomas' Hospital, King's College, London, England (Drs Lens and Bataille); and Mount Vernon Cancer Centre, Northwood, England (Dr Nathan).


RELATED ARTICLE

Excision Margins for Primary Cutaneous Melanoma—Invited Critique
Charles M. Balch, Merrick I. Ross, Natale Cascinelli, and Seng-jaw Soong
Arch Surg. 2007;142(9):891-893.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.